Levoleucovorin Calcium was first introduced by Acrotech Biopharma Inc in its drug Fusilev on Mar 7, 2008. Another drug containing Levoleucovorin Calcium is Levoleucovorin Calcium. 11 different companies have introduced drugs containing Levoleucovorin Calcium.
Levoleucovorin Calcium Patents
Given below is the list of patents protecting Levoleucovorin Calcium, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Levoleucovorin Calcium Generic API Manufacturers
Several generic applications have been filed for Levoleucovorin Calcium. The first generic version for Levoleucovorin Calcium was by Sandoz Inc and was approved on Mar 9, 2015. And the latest generic version is by Hainan Poly Pharmaceutical Co Ltd and was approved on May 22, 2023.
Given below is the list of companies who have filed for
Levoleucovorin Calcium generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LLC
Actavis Llc has filed for 1 generic for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Actavis Llc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
powder
Discontinued
INTRAVENOUS
N/A
Feb 13, 2017
Manufacturing Plant Locations
New
Actavis Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Llc as present at those locations.
Country
City
Firm Name
United States
Edison
Actavis LLC
2. AMNEAL
Amneal Eu Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Amneal.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
powder
Discontinued
INTRAVENOUS
N/A
Feb 13, 2017
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
solution
Prescription
INTRAVENOUS
AP
Sep 8, 2017
Manufacturing Plant Locations
New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
Country
City
Firm Name
United States
Paterson
Amneal Pharmaceuticals, Llc
East Hanover
Amneal Pharmaceuticals LLC
Branchburg
Amneal Pharmaceuticals, LLC
Piscataway
Amneal Pharmaceuticals, LLC
Bridgewater
Amneal Complex Products Research LLC
Brookhaven
Amneal Pharmaceuticals of New York, LLC
Hauppauge
Amneal Pharmaceuticals of New York, LLC
Glasgow
Amneal Pharmaceuticals LLC
India
Ahmedabad
Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad
Amneal Pharmaceuticals Pvt. Ltd.
Matoda
Amneal Pharmaceuticals Private Ltd.
Hyderabad
Amneal Oncology Private Limited
3. GLAND
Gland Pharma Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Gland.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
(reference standard)
solution
Prescription
INTRAVENOUS
AP
Sep 14, 2018
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
solution
Prescription
INTRAVENOUS
AP
Sep 14, 2018
Manufacturing Plant Locations
New
Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.
Country
City
Firm Name
India
Visakhapatnam
Gland Pharma Limited
Sriperumbudur
Gland Chemical Private Limited
Parawada, Visakhapatnam
Gland Pharma Limited
Hyderabad
Gland Pharma Limited, Units I+II Pashamylaram Site
Hyderabad
Gland Pharma Limited
Aurangabad
Gland Chemical Private Limited
Malur
Gland Chemicals Pvt Ltd.
4. HAINAN POLY PHARM
Hainan Poly Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Hainan Poly Pharm.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
solution
Prescription
INTRAVENOUS
AP
May 22, 2023
EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
solution
Prescription
INTRAVENOUS
AP
May 22, 2023
Manufacturing Plant Locations
New
Hainan Poly Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly Pharm as present at those locations.
Country
City
Firm Name
China
Haikou
Hainan Poly Pharm. Co., Ltd.
5. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 50MG BASE/VIAL
powder
Discontinued
INTRAVENOUS
N/A
Jun 16, 2016
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Eatontown
Hikma Pharmaceuticals USA, Inc.
Dayton
Hikma Injectables USA Inc
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
6. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 3 different strengths of generic version for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Meitheal.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
(reference standard)
solution
Prescription
INTRAVENOUS
AP
Aug 16, 2019
EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
solution
Discontinued
INTRAVENOUS
N/A
Aug 16, 2019
EQ 50MG BASE/VIAL
powder
Discontinued
INTRAVENOUS
N/A
Aug 22, 2019
7. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Norvium Bioscience.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
solution
Discontinued
INTRAVENOUS
N/A
Oct 20, 2015
EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
solution
Discontinued
INTRAVENOUS
N/A
Oct 20, 2015
8. NOVAST LABS
Novast Laboratories Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Novast Labs.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
solution
Discontinued
INTRAVENOUS
N/A
May 3, 2018
EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
solution
Discontinued
INTRAVENOUS
N/A
May 3, 2018
9. PRAXGEN
Praxgen Pharmaceuticals Llc has filed for 1 generic for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Praxgen.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
solution
Discontinued
INTRAVENOUS
N/A
Nov 2, 2021
Manufacturing Plant Locations
New
Praxgen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Praxgen as present at those locations.
Country
City
Firm Name
United States
Monmouth Junction
Praxgen Pharmaceuticals, LLC
10. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the
details of the strengths of this generic introduced by
Sandoz.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
solution
Prescription
INTRAVENOUS
AP
Mar 9, 2015
EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
solution
Discontinued
INTRAVENOUS
N/A
Mar 9, 2015
Manufacturing Plant Locations
New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
